Sean Smith

Insider Reports History

Location
Seattle, WA
Signature
/s/ Sean Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neoleukin Therapeutics, Inc. Interim CFO, Prin Acct Off Common Stock 21,637 $14,990 $0.6928 11 Aug 2023 Direct
Neoleukin Therapeutics, Inc. Interim CFO, Prin Acct Off Restricted Stock Units 0 10 Aug 2023 Direct

Insider Reports Filed by Sean Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NGNE Neoleukin Therapeutics, Inc. 10 Aug 2023 3 -$818 4 Interim CFO, Prin Acct Off 14 Aug 2023, 16:06
NGNE Neoleukin Therapeutics, Inc. 01 Feb 2023 3 -$1,980 4 Principal Accounting Officer 03 Feb 2023, 15:33
NGNE Neoleukin Therapeutics, Inc. 10 Aug 2022 3 -$1,641 4 Principal Accounting Officer 12 Aug 2022, 17:24
NGNE Neoleukin Therapeutics, Inc. 02 Aug 2022 1 $0 4 Principal Accounting Officer 04 Aug 2022, 16:41
NGNE Neoleukin Therapeutics, Inc. 02 Mar 2022 1 $0 4 Principal Accounting Officer 03 Mar 2022, 15:39
NGNE Neoleukin Therapeutics, Inc. 02 Mar 2022 0 $0 3 Principal Accounting Officer 03 Mar 2022, 15:38